Eliem Therapeutics Cash from Financing (TTM) Trends

Eliem Therapeutics Inc (ELYM)

10.16 +1.76 (+21.04%) USD | NASDAQ | May 03, 16:00

10.14 -0.02 (-0.15%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2020. Upgrade now.

Date	Value
December 31, 2023	0.841M
September 30, 2023	0.553M
June 30, 2023	0.025M
March 31, 2023	0.001M
December 31, 2022	0.00
September 30, 2022	0.038M
June 30, 2022	83.18M

Date	Value
March 31, 2022	143.15M
December 31, 2021	177.23M
September 30, 2021	182.12M
June 30, 2021	98.98M
March 31, 2021	39.01M
December 31, 2020	4.925M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Dec 2022

182.12M

Maximum

Sep 2021

56.16M

Average

4.925M

Median

Dec 2020

Cash from Financing (TTM) Benchmarks